Logo image of SLXN

SILEXION THERAPEUTICS CORP (SLXN) Stock Earnings & Estimates

NASDAQ:SLXN - KYG1281K1224 - Common Stock

7.15 USD
+0.15 (+2.14%)
Last: 9/5/2025, 8:00:02 PM
6.98 USD
-0.17 (-2.38%)
After Hours: 9/5/2025, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
SLXN revenue by date.SLXN revenue by date.
N/AN/AN/AN/AN/A
EBITDA
YoY % growth
SLXN ebitda by date.SLXN ebitda by date.
N/AN/AN/A-6M-12.546M
-109.09%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
SLXN ebit by date.SLXN ebit by date.
-200K-770K
-285.00%
-1.11M
-44.16%
-6.045M
-444.63%
-12.571M
-107.94%
N/A
30.30%
N/A
-17.82%
N/A
-26.61%
N/AN/A
Operating Margin
SLXN operating margin by date.SLXN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SLXN eps by date.SLXN eps by date.
N/AN/AN/AN/AN/AN/A
92.88%
N/A
38.56%
N/A
1.08%
N/A
-3.82%
N/A
26.41%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-3.47
-70.84%
-1.93
99.38%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-2.363M
70.59%
-2.386M
-25.57%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-4.32 -3.67-0.65-17.65%
Q1 2025
Q2Q % growth
-3.90 -3.37-0.53-15.86%
Q4 2024
Q2Q % growth
-311.40 -14.99-296.41-1,976.83%
SLXN Yearly EPS VS EstimatesSLXN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 -50 -100 -150
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS9.33% N/A -1156.25% -1156.25%
RevenueN/A N/A N/A N/A